Literature DB >> 11158220

Identification of receptor ligands by screening phage-display peptide libraries ex vivo on microdissected kidney tubules.

Alex Odermatt1, Annette Audigé1, Christoph Frick1, Bruno Vogt1, Brigitte M Frey1, Felix J Frey1, Luca Mazzucchelli2.   

Abstract

A novel method to identify receptor ligands for defined renal tubular segments has been developed. Ex vivo screening of phage-display peptide libraries on isolated intact rat proximal convoluted tubules (PCT) and cortical collecting ducts (CCD) allowed the direct access of phage to the basolateral surface of tubular epithelial cells. Two distinct peptide motifs were selected for CCD and PCT, indicating differential expression of some membrane receptors on the basolateral surface of defined kidney tubule segments. Using the linear peptide motif ELRGD(R/M)AX(W/L), recovered from freshly isolated rat CCD, mediated 16-fold selectivity of phage binding to CCD compared with PCT. Binding to CCD was 39-fold higher than that of a random control phage. Binding and subsequent internalization of phage, most likely by an integrin-mediated endocytosis pathway, was abolished by the addition of the corresponding synthetic peptide. Furthermore, the results demonstrate that presentation and flanking amino acids determine the specific binding properties of RGD ligands to their putative integrin receptors. The results emphasize the need of a native cell system for the identification of renal epithelial cell surface ligands. Such ligands are of potential relevance for the analysis of interactions between extracellular matrix and kidney tubules or for the development of improved vectors for kidney-specific drug delivery or gene transfer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158220     DOI: 10.1681/ASN.V122308

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  8 in total

1.  In vitro selection of a peptide antagonist of growth hormone secretagogue receptor using cDNA display.

Authors:  Shingo Ueno; Sayaka Yoshida; Anupom Mondal; Kazuya Nishina; Makoto Koyama; Ichiro Sakata; Kenju Miura; Yujiro Hayashi; Naoto Nemoto; Koichi Nishigaki; Takafumi Sakai
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-20       Impact factor: 11.205

Review 2.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

3.  A Urinary Drug-Disposing Approach as an Alternative to Intravesical Chemotherapy for Treating Nonmuscle Invasive Bladder Cancer.

Authors:  Vanessa Bellat; Adam O Michel; Charlene Thomas; Tracy Stokol; Benjamin B Choi; Benedict Law
Journal:  Cancer Res       Date:  2022-04-01       Impact factor: 12.701

4.  Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.

Authors:  Jonathan Wang; Jacqueline J Masehi-Lano; Eun Ji Chung
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

Review 5.  Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions.

Authors:  Yi Huang; Jonathan Wang; Kairui Jiang; Eun Ji Chung
Journal:  J Control Release       Date:  2021-04-20       Impact factor: 11.467

Review 6.  In Vitro Selection of Cancer Cell-Specific Molecular Recognition Elements from Amino Acid Libraries.

Authors:  Ryan M Williams; Letha J Sooter
Journal:  J Immunol Res       Date:  2015-09-07       Impact factor: 4.818

7.  Biopanning of polypeptides binding to bovine ephemeral fever virus G1 protein from phage display peptide library.

Authors:  Peili Hou; Guimin Zhao; Chengqiang He; Hongmei Wang; Hongbin He
Journal:  BMC Vet Res       Date:  2018-01-04       Impact factor: 2.741

Review 8.  Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancer.

Authors:  Julia Reetz; Ottmar Herchenröder; Brigitte M Pützer
Journal:  Viruses       Date:  2014-04-02       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.